181 related articles for article (PubMed ID: 485611)
1. Specific active immunotherapy for melanoma.
Seigler HF; Cox E; Mutzner F; Shepherd L; Nicholson E; Shingleton WW
Ann Surg; 1979 Sep; 190(3):366-72. PubMed ID: 485611
[No Abstract] [Full Text] [Related]
2. Immunotherapy for malignant melanoma with a tumor cell vaccine.
Slingluff CL; Seigler HF
Ann Plast Surg; 1992 Jan; 28(1):104-7. PubMed ID: 1642395
[TBL] [Abstract][Full Text] [Related]
3. [Immunotherapy of malignant melanomas].
Macher E
Haematol Blood Transfus; 1978; 21():285-91. PubMed ID: 738638
[No Abstract] [Full Text] [Related]
4. Experience with BCG adjuvant immunotherapy in stage II malignant melanoma.
Peter HH; Deutschmann EM; Schultheis W; Deicher H
Dev Biol Stand; 1977 Apr 13-15; 38():537-40. PubMed ID: 344106
[TBL] [Abstract][Full Text] [Related]
5. [Immunotherapy with BCG as coadjuvant in the management of malignant melanomas].
Céspedes de Gómez MM; Aguilar Velázquez G; Valles de Cortés Y
Alergia; 1980 Apr; 27(2):69-86. PubMed ID: 7416444
[No Abstract] [Full Text] [Related]
6. [Immunotherapy of malignant melanoma].
Adler A
Harefuah; 1986 Jul; 111(1-2):11-7. PubMed ID: 3781371
[No Abstract] [Full Text] [Related]
7. Immunotherapy of melanoma with intralesional BCG.
Bornstein RS; Mastrangelo MJ; Sulit H; Chee D; Yarbro JW; Prehn LM; Prehn RT
Natl Cancer Inst Monogr; 1973 Dec; 39():213-20. PubMed ID: 4595320
[No Abstract] [Full Text] [Related]
8. Mumps virus and BCG vaccine in metastatic melanoma.
Minton JP
Arch Surg; 1973 Apr; 106(4):503-6. PubMed ID: 4572347
[No Abstract] [Full Text] [Related]
9. Next generation of immunotherapy for melanoma.
Kirkwood JM; Tarhini AA; Panelli MC; Moschos SJ; Zarour HM; Butterfield LH; Gogas HJ
J Clin Oncol; 2008 Jul; 26(20):3445-55. PubMed ID: 18612161
[TBL] [Abstract][Full Text] [Related]
10. [Immunological aspects of melanoma].
Sjögren H
Lakartidningen; 1976 Feb; 73(7):528-30. PubMed ID: 1250045
[No Abstract] [Full Text] [Related]
11. [Cancer immunotherapy in dermatological view (author's transl)].
Lübbe D; Gstöttner R
Arch Geschwulstforsch; 1980; 50(2):182-5. PubMed ID: 7436703
[TBL] [Abstract][Full Text] [Related]
12. Active specific and active non-specific immunotherapy in patients with malignant melanoma.
Kokoschka EM; Cerni C; Micksche M
Oncology; 1977; 34(5):229-33. PubMed ID: 917456
[TBL] [Abstract][Full Text] [Related]
13. [BCG-treatment of malignant melanoma].
Borberg H
Internist (Berl); 1975 Oct; 16(10):482-5. PubMed ID: 1107254
[No Abstract] [Full Text] [Related]
14. [Intranodular treatment with BCG of cutaneous and subcutaneous metastases of malignant melanoma (author's transl)].
Balzarini GP; Cascinelli N; Fontana V; Veronesi U
Tumori; 1974; 60(4):345-52. PubMed ID: 4439501
[No Abstract] [Full Text] [Related]
15. BCG in the treatment of human cancer.
Terry WD
CA Cancer J Clin; 1975; 25(4):198-203. PubMed ID: 805639
[No Abstract] [Full Text] [Related]
16. Experience with BCG adjuvant immunotherapy in stage II malignant melanoma.
Deutschmann KE; Peter HH; Schultheis W; Deicher H
Tumori; 1977; 63(3):303-7. PubMed ID: 898298
[TBL] [Abstract][Full Text] [Related]
17. [Results in the use of immunochemotherapy in patients with cutaneous malignant melanoma].
Calbo L; Gorgone S; Palmeri R; Salibra M; Melita P
Chir Ital; 1983 Aug; 35(4):519-25. PubMed ID: 6680859
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant immunostimulation in malignant melanoma with oral Bacille Calmette-Guérin.
MacGregor AB; Falk RE; Landi S; Ambus U; Samuel ES; Langer B
Can J Surg; 1977 Jan; 20(1):25-30. PubMed ID: 832200
[TBL] [Abstract][Full Text] [Related]
19. Intralesional immunotherapy of melanoma with BCG.
Rosenberg SA; Rapp HJ
Med Clin North Am; 1976 May; 60(3):419-30. PubMed ID: 1271887
[TBL] [Abstract][Full Text] [Related]
20. [Immunologic aspects of the treatment of melanoma].
Pawlowska EM
Pol Tyg Lek; 1977 Jun; 32(24):939-41. PubMed ID: 882435
[No Abstract] [Full Text] [Related]
[Next] [New Search]